tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports

Aprea Therapeutics (APRE) Stock News & Sentiment

500 Followers
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
Premium
Company Announcements
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
11d ago
8K
APRE
Aprea Therapeutics Announces $30 Million Private Placement
Premium
Company Announcements
Aprea Therapeutics Announces $30 Million Private Placement
13d ago
8K
APRE
Aprea Highlights Early APR-1051 Data and Financial Update
Premium
Company Announcements
Aprea Highlights Early APR-1051 Data and Financial Update
28d ago
8K
APRE
Aprea Therapeutics: Emerging Dose-Responsive Efficacy and Favorable Safety of APR-1051 Underpin Buy Rating
Premium
Ratings
Aprea Therapeutics: Emerging Dose-Responsive Efficacy and Favorable Safety of APR-1051 Underpin Buy Rating
2M ago
APRE
Aprea Highlights Encouraging Phase 1 Data for APR-1051
Premium
Company Announcements
Aprea Highlights Encouraging Phase 1 Data for APR-1051
2M ago
8K
APRE
APR-1051’s Emerging Best-in-Class WEE1 Profile Underpins Buy Rating on Aprea Therapeutics
Premium
Ratings
APR-1051’s Emerging Best-in-Class WEE1 Profile Underpins Buy Rating on Aprea Therapeutics
2M ago
APRE
Aprea Therapeutics Announces Financing and Early Trial Response
Premium
Company Announcements
Aprea Therapeutics Announces Financing and Early Trial Response
2M ago
8K
APRE
More APRE News >

APRE News on the Web

Maxim Group Reaffirms Their Buy Rating on Aprea Therapeutics (APRE)
TipRanks News
Bullish
Aprea Therapeutics Closes Oversubscribed $30 Mln Private Placement; Stock Down
rttnews
Bearish
Aprea Therapeutics Raises $30M to Advance Oncology Pipeline
TipRanks News
Neutral
Aprea Therapeutics price target lowered to $1.20 from $4 at H.C. Wainwright
TipRanks News
Bearish
Aprea Therapeutics Announces $30 Million Private Placement
TipRanks News
Neutral
Aprea Reports Confirmed Partial Response In APR-1051 Trial And Announced $30M Private Placement
rttnews
Bullish
Aprea Therapeutics confirms partial response in ongoing ACESOT-1051 trial
TipRanks News
Bullish
Wedbush Keeps Their Buy Rating on Aprea Therapeutics (APRE)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
APRE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APRE’s Media Buzz Sentiment?
1 articles about APRE were published this week. In an average week, 2 articles are published.
    What is APRE’s weekly average amount of articles?
    In an average week, 2 articles about APRE are published.
      What is APRE’s News Sentiment?
      100% of articles about APRE were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week